NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-215-2017-0-AU-03 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES AU National Stage 2019216241 Issued
NCI E-175-2016-0-EP-06 ANTI-KRAS-G12D T CELL RECEPTORS EP National Stage 17749580.1 Issued
NCI E-231-2015-0-US-09 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) OF SUPPRESSOR CELLS TO TREAT CANCER US National Stage 15/749,028 11013803 Issued PDF
NCI E-175-2016-0-US-08 ANTI-KRAS-G12D T CELL RECEPTORS US National Stage 16/321,899 10611816 Issued PDF
NCI E-215-2017-0-PCT-02 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES PCT PCT PCT/US2019/015763 Expired
NCI E-195-2018-0-US-01 Measurement Of Heterodimer Complex Of BIM---Bcl-2, BIM---Bcl-xL, BIM---Mcl-1 And BAX---BAK As Diagnostic Test Of Patient Sensitivity To BH3 Mimetics US 62/798,615 Abandoned
NIBIB E-047-2019-0-US-01 CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE US 62/798,763 Abandoned
CC E-096-2016-0-US-03 POWERED GAIT ASSISTANCE SYSTEMS US National Stage 16/321,565 11801153 Issued PDF
NIMH E-448-2013-0-US-06 Antineuronal Antibodies In Pediatric Acute Neurologic Syndrome For Diagnosis And Treatment US CON 16/259,062 Abandoned
CC E-277-2015-0-US-04 Sensorless Transperineal Ultrasound-MRI Fusion Guided Prostate Biopsy US National Stage 16/320,980 11504154 Issued PDF
NCI E-119-2013-0-US-04 METHOD FOR SYNTHESIZING SELECTIVELY LABELED RNA US CON 16/258,021 11041182 Issued PDF
NCI E-115-2016-0-US-03 Fluorine-18 Labeling Of Peptide For PET Imaging Study Of Over-expression Of C-MET US National Stage 16/320,645 Abandoned
NINDS E-208-2020-0-US-01 Targeting The 5'UTR Of Survival Motor Neuron 2 (SMN2) To Increase Its Expression In A Disease Model Of Spinal Muscular Atrophy (SMA) US 62/796,748 Abandoned
NEI E-044-2018-0-US-02 EXOSOMES AND MIRNA TO TREAT GLAUCOMA US ORD 16/257,026 11058729 Issued PDF
NCI E-175-2016-0-SG-11 ANTI-KRAS-G12D T CELL RECEPTORS SG National Stage 11201900654Q Pending
NICHD E-173-2016-0-AU-03 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS AU National Stage 2017310513 Issued
NHLBI E-121-2016-1-JP-04 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE JP National Stage 2019-503538 Issued
NINDS E-009-2019-0-US-01 Automated Identification Of Subjects At Risks Of Multiple Sclerosis (AIMS) US ORD 16/254,710 11272843 Issued PDF
NCI E-105-2012-0-AT-28 MURINE ANTI-NY-ESO-1 T CELL RECEPTORS AT EP 19152955.1 Issued
NCI E-105-2012-0-IT-36 Murine Anti-NY-ESO-1 T Cell Receptors IT EP 19152955.1 Issued
NCI E-105-2012-0-IE-35 Murine Anti-NY-ESO-1 T Cell Receptors IE EP 19152955.1 Issued
NCI E-105-2012-0-CH-30 Medical Use of Cells Comprising Anti-NY-ESO-1 T Cell Receptors CH EP 19152955.1 Issued
NCI E-105-2012-0-GB-34 Murine Anti-NY-ESO-1 T Cell Receptors GB EP 19152955.1 Issued
NCI E-105-2012-0-NL-37 Murine Anti-NY-ESO-1 T Cell Receptors NL EP 19152955.1 Issued
NCI E-105-2012-0-BE-29 Murine Anti-NY-ESO-1 T Cell Receptors BE EP 19152955.1 Issued
NCI E-105-2012-0-PT-38 Murine Anti-NY-ESO-1 T Cell Receptors PT EP 19152955.1 Issued
NCI E-105-2012-0-ES-32 Murine Anti-NY-ESO-1 T Cell Receptors ES EP 19152955.1 Issued
NCI E-105-2012-0-EP-15 Murine Anti-NY-ESO-1 T Cell Receptors EP DIV 19152955.1 Issued
NCI E-105-2012-0-FR-33 Murine Anti-NY-ESO-1 T Cell Receptors FR EP 19152955.1 Issued
NCI E-105-2012-0-DE-31 Murine Anti-NY-ESO-1 T Cell Receptors DE EP 19152955.1 Issued
NCI E-029-2019-0-US-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION US 62/795,203 Abandoned
NCI E-028-2019-0-US-01 High Affinity Monoclonal Antibodies Targeting Glypican-1 For Treating Pancreatic Cancer US 62/795,415 Abandoned
NEI E-284-2012-2-PCT-08 METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE PCT PCT PCT/US2019/014418 Expired
NIAID E-146-2004-0-US-05 Monoclonal Antibodies that Neutralize Anthrax Protective Antigen (PA) Toxin US DIV 16/253,077 Abandoned
NCI E-094-2017-2-US-03 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment US CON 16/252,158 10550179 Issued PDF
NIAID E-033-2018-0-PCT-02 Development Of A Broadly Protective Influenza Vaccine Consisting Of A Cocktail Of Inactivated Avian Influenza Viruses 1 PCT PCT PCT/US2019/014220 Expired
NCI E-236-2017-0-PCT-02 Anti-cancer Activity Of SCGB3A2 PCT PCT PCT/US2019/014189 Expired
NIAID E-033-2018-0-CN-03 BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE CN National Stage 201980009484.7 Pending
NIAID E-033-2018-0-EP-04 BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE EP National Stage 19717381.8 Pending
NIAID E-033-2018-0-IN-05 Development Of A Broadly Protective Influenza Vaccine Consisting Of A Cocktail Of Inactivated Avian Influenza Viruses 1 IN National Stage 202017031357 Pending
NCI E-031-2014-0-US-05 COMPOSITIONS COMPRISING PCSK9 PEPTIDE CONJUGATED TO A QBETA CARRIER AND METHODS OF USING THE SAME US CON 16/250,514 10925938 Issued PDF
NIA E-214-2018-0-PCT-02 PHENOTYPIC AGE AND DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY PCT PCT PCT/US2019/014053 Expired
NIA E-214-2018-0-EP-03 PHENOTYPIC AGE AND DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY EP National Stage 19741202.6 Pending
NEI E-134-2016-0-AU-03 Selective Estrogen-receptor Modulators (SERMs) Confer Protection Against Photoreceptor Degeneration AU National Stage 2017312499 Issued
NIAID E-099-2016-0-US-16 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/249,721 10682379 Abandoned PDF
NIAID E-096-2019-0-US-01 NHIV-Specific CD8+ T Cell Receptors From Long-Term Nonprogressors/Elite Controllers US 62/792,880 Abandoned
NIDA E-057-2018-1-US-01 Focused Small Animal Transcranial Magnetic Stimulator US 62/791,753 Abandoned
NCI E-019-2019-0-US-01 Small Particle Calibration Kit For Flow Cytometry US 62/791,327 Abandoned
NIAID E-099-2016-0-US-15 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/244,903 Abandoned
NHGRI E-031-2018-0-PCT-02 DETECTING PROTEIN INTERACTION SITES IN NUCLEIC ACIDS PCT PCT PCT/US2019/012851 Expired